FDA OKs Farxiga for Heart Failure With Reduced Ejection Fraction

WEDNESDAY, May 6, 2020 — The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday.
Farxiga is the first…
Source: Topamax